COVID-19 Impact on Global Liver Failure Therapeutics Market Size, Status and Forecast 2020-2026

September 2020 | 90 pages | ID: C0C458CFE3A0EN
QYResearch

Abstracts

This report focuses on the global Liver Failure Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Liver Failure Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Alfact Innovation
• BioLineRx Ltd
• Cell2B Advanced Therapeutics SA
• Conatus Pharmaceuticals Inc
• Immune Pharmaceuticals Inc
• Mina Therapeutics Ltd
• Mylan NV
• Ocera Therapeutics Inc
• PledPharma AB
• Promethera Biosciences SA
• Silence Therapeutics Plc
• Unicyte AG
• Ventria Bioscience
• Vital Therapies Inc

Market segment by Type, the product can be split into

• Ornithine Phenylacetate
• MTL-CEBPA
• F-573
• BL-1220
• PP-100
• Others

Market segment by Application, split into

• Clinic
• Hospital
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Liver Failure Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Liver Failure Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Liver Failure Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Liver Failure Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Liver Failure Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Ornithine Phenylacetate
  1.4.3 MTL-CEBPA
  1.4.4 F-573
  1.4.5 BL-1220
  1.4.6 PP-100
  1.4.7 Others
1.5 Market by Application
  1.5.1 Global Liver Failure Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Clinic
  1.5.3 Hospital
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Liver Failure Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Liver Failure Therapeutics Industry
    1.6.1.1 Liver Failure Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Liver Failure Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Liver Failure Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Liver Failure Therapeutics Market Perspective (2015-2026)
2.2 Liver Failure Therapeutics Growth Trends by Regions
  2.2.1 Liver Failure Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Liver Failure Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Liver Failure Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Liver Failure Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Liver Failure Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Liver Failure Therapeutics Players by Market Size
  3.1.1 Global Top Liver Failure Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Liver Failure Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Liver Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Liver Failure Therapeutics Market Concentration Ratio
  3.2.1 Global Liver Failure Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Liver Failure Therapeutics Revenue in 2019
3.3 Liver Failure Therapeutics Key Players Head office and Area Served
3.4 Key Players Liver Failure Therapeutics Product Solution and Service
3.5 Date of Enter into Liver Failure Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Liver Failure Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Liver Failure Therapeutics Forecasted Market Size by Type (2021-2026)

5 LIVER FAILURE THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Liver Failure Therapeutics Market Size by Application (2015-2020)
5.2 Global Liver Failure Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Liver Failure Therapeutics Market Size (2015-2020)
6.2 Liver Failure Therapeutics Key Players in North America (2019-2020)
6.3 North America Liver Failure Therapeutics Market Size by Type (2015-2020)
6.4 North America Liver Failure Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Liver Failure Therapeutics Market Size (2015-2020)
7.2 Liver Failure Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Liver Failure Therapeutics Market Size by Type (2015-2020)
7.4 Europe Liver Failure Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Liver Failure Therapeutics Market Size (2015-2020)
8.2 Liver Failure Therapeutics Key Players in China (2019-2020)
8.3 China Liver Failure Therapeutics Market Size by Type (2015-2020)
8.4 China Liver Failure Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Liver Failure Therapeutics Market Size (2015-2020)
9.2 Liver Failure Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Liver Failure Therapeutics Market Size by Type (2015-2020)
9.4 Japan Liver Failure Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Liver Failure Therapeutics Market Size (2015-2020)
10.2 Liver Failure Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Liver Failure Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Liver Failure Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Liver Failure Therapeutics Market Size (2015-2020)
11.2 Liver Failure Therapeutics Key Players in India (2019-2020)
11.3 India Liver Failure Therapeutics Market Size by Type (2015-2020)
11.4 India Liver Failure Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Liver Failure Therapeutics Market Size (2015-2020)
12.2 Liver Failure Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Liver Failure Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Liver Failure Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Alfact Innovation
  13.1.1 Alfact Innovation Company Details
  13.1.2 Alfact Innovation Business Overview and Its Total Revenue
  13.1.3 Alfact Innovation Liver Failure Therapeutics Introduction
  13.1.4 Alfact Innovation Revenue in Liver Failure Therapeutics Business (2015-2020))
  13.1.5 Alfact Innovation Recent Development
13.2 BioLineRx Ltd
  13.2.1 BioLineRx Ltd Company Details
  13.2.2 BioLineRx Ltd Business Overview and Its Total Revenue
  13.2.3 BioLineRx Ltd Liver Failure Therapeutics Introduction
  13.2.4 BioLineRx Ltd Revenue in Liver Failure Therapeutics Business (2015-2020)
  13.2.5 BioLineRx Ltd Recent Development
13.3 Cell2B Advanced Therapeutics SA
  13.3.1 Cell2B Advanced Therapeutics SA Company Details
  13.3.2 Cell2B Advanced Therapeutics SA Business Overview and Its Total Revenue
  13.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Introduction
  13.3.4 Cell2B Advanced Therapeutics SA Revenue in Liver Failure Therapeutics Business (2015-2020)
  13.3.5 Cell2B Advanced Therapeutics SA Recent Development
13.4 Conatus Pharmaceuticals Inc
  13.4.1 Conatus Pharmaceuticals Inc Company Details
  13.4.2 Conatus Pharmaceuticals Inc Business Overview and Its Total Revenue
  13.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Introduction
  13.4.4 Conatus Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2015-2020)
  13.4.5 Conatus Pharmaceuticals Inc Recent Development
13.5 Immune Pharmaceuticals Inc
  13.5.1 Immune Pharmaceuticals Inc Company Details
  13.5.2 Immune Pharmaceuticals Inc Business Overview and Its Total Revenue
  13.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Introduction
  13.5.4 Immune Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2015-2020)
  13.5.5 Immune Pharmaceuticals Inc Recent Development
13.6 Mina Therapeutics Ltd
  13.6.1 Mina Therapeutics Ltd Company Details
  13.6.2 Mina Therapeutics Ltd Business Overview and Its Total Revenue
  13.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Introduction
  13.6.4 Mina Therapeutics Ltd Revenue in Liver Failure Therapeutics Business (2015-2020)
  13.6.5 Mina Therapeutics Ltd Recent Development
13.7 Mylan NV
  13.7.1 Mylan NV Company Details
  13.7.2 Mylan NV Business Overview and Its Total Revenue
  13.7.3 Mylan NV Liver Failure Therapeutics Introduction
  13.7.4 Mylan NV Revenue in Liver Failure Therapeutics Business (2015-2020)
  13.7.5 Mylan NV Recent Development
13.8 Ocera Therapeutics Inc
  13.8.1 Ocera Therapeutics Inc Company Details
  13.8.2 Ocera Therapeutics Inc Business Overview and Its Total Revenue
  13.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Introduction
  13.8.4 Ocera Therapeutics Inc Revenue in Liver Failure Therapeutics Business (2015-2020)
  13.8.5 Ocera Therapeutics Inc Recent Development
13.9 PledPharma AB
  13.9.1 PledPharma AB Company Details
  13.9.2 PledPharma AB Business Overview and Its Total Revenue
  13.9.3 PledPharma AB Liver Failure Therapeutics Introduction
  13.9.4 PledPharma AB Revenue in Liver Failure Therapeutics Business (2015-2020)
  13.9.5 PledPharma AB Recent Development
13.10 Promethera Biosciences SA
  13.10.1 Promethera Biosciences SA Company Details
  13.10.2 Promethera Biosciences SA Business Overview and Its Total Revenue
  13.10.3 Promethera Biosciences SA Liver Failure Therapeutics Introduction
  13.10.4 Promethera Biosciences SA Revenue in Liver Failure Therapeutics Business (2015-2020)
  13.10.5 Promethera Biosciences SA Recent Development
13.11 Silence Therapeutics Plc
  10.11.1 Silence Therapeutics Plc Company Details
  10.11.2 Silence Therapeutics Plc Business Overview and Its Total Revenue
  10.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Introduction
  10.11.4 Silence Therapeutics Plc Revenue in Liver Failure Therapeutics Business (2015-2020)
  10.11.5 Silence Therapeutics Plc Recent Development
13.12 Unicyte AG
  10.12.1 Unicyte AG Company Details
  10.12.2 Unicyte AG Business Overview and Its Total Revenue
  10.12.3 Unicyte AG Liver Failure Therapeutics Introduction
  10.12.4 Unicyte AG Revenue in Liver Failure Therapeutics Business (2015-2020)
  10.12.5 Unicyte AG Recent Development
13.13 Ventria Bioscience
  10.13.1 Ventria Bioscience Company Details
  10.13.2 Ventria Bioscience Business Overview and Its Total Revenue
  10.13.3 Ventria Bioscience Liver Failure Therapeutics Introduction
  10.13.4 Ventria Bioscience Revenue in Liver Failure Therapeutics Business (2015-2020)
  10.13.5 Ventria Bioscience Recent Development
13.14 Vital Therapies Inc
  10.14.1 Vital Therapies Inc Company Details
  10.14.2 Vital Therapies Inc Business Overview and Its Total Revenue
  10.14.3 Vital Therapies Inc Liver Failure Therapeutics Introduction
  10.14.4 Vital Therapies Inc Revenue in Liver Failure Therapeutics Business (2015-2020)
  10.14.5 Vital Therapies Inc Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Liver Failure Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Liver Failure Therapeutics Revenue
Table 3. Ranking of Global Top Liver Failure Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Liver Failure Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ornithine Phenylacetate
Table 6. Key Players of MTL-CEBPA
Table 7. Key Players of F-573
Table 8. Key Players of BL-1220
Table 9. Key Players of PP-100
Table 10. Key Players of Others
Table 11. COVID-19 Impact Global Market: (Four Liver Failure Therapeutics Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Liver Failure Therapeutics Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Liver Failure Therapeutics Players to Combat Covid-19 Impact
Table 16. Global Liver Failure Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global Liver Failure Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global Liver Failure Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global Liver Failure Therapeutics Market Share by Regions (2015-2020)
Table 20. Global Liver Failure Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global Liver Failure Therapeutics Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. Liver Failure Therapeutics Market Growth Strategy
Table 26. Main Points Interviewed from Key Liver Failure Therapeutics Players
Table 27. Global Liver Failure Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 28. Global Liver Failure Therapeutics Market Share by Players (2015-2020)
Table 29. Global Top Liver Failure Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Failure Therapeutics as of 2019)
Table 30. Global Liver Failure Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players Liver Failure Therapeutics Product Solution and Service
Table 33. Date of Enter into Liver Failure Therapeutics Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. Global Liver Failure Therapeutics Market Size Share by Type (2015-2020)
Table 37. Global Liver Failure Therapeutics Revenue Market Share by Type (2021-2026)
Table 38. Global Liver Failure Therapeutics Market Size Share by Application (2015-2020)
Table 39. Global Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. Global Liver Failure Therapeutics Market Size Share by Application (2021-2026)
Table 41. North America Key Players Liver Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 42. North America Key Players Liver Failure Therapeutics Market Share (2019-2020)
Table 43. North America Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. North America Liver Failure Therapeutics Market Share by Type (2015-2020)
Table 45. North America Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. North America Liver Failure Therapeutics Market Share by Application (2015-2020)
Table 47. Europe Key Players Liver Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players Liver Failure Therapeutics Market Share (2019-2020)
Table 49. Europe Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. Europe Liver Failure Therapeutics Market Share by Type (2015-2020)
Table 51. Europe Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. Europe Liver Failure Therapeutics Market Share by Application (2015-2020)
Table 53. China Key Players Liver Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 54. China Key Players Liver Failure Therapeutics Market Share (2019-2020)
Table 55. China Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. China Liver Failure Therapeutics Market Share by Type (2015-2020)
Table 57. China Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. China Liver Failure Therapeutics Market Share by Application (2015-2020)
Table 59. Japan Key Players Liver Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players Liver Failure Therapeutics Market Share (2019-2020)
Table 61. Japan Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Japan Liver Failure Therapeutics Market Share by Type (2015-2020)
Table 63. Japan Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Japan Liver Failure Therapeutics Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players Liver Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players Liver Failure Therapeutics Market Share (2019-2020)
Table 67. Southeast Asia Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia Liver Failure Therapeutics Market Share by Type (2015-2020)
Table 69. Southeast Asia Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia Liver Failure Therapeutics Market Share by Application (2015-2020)
Table 71. India Key Players Liver Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 72. India Key Players Liver Failure Therapeutics Market Share (2019-2020)
Table 73. India Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. India Liver Failure Therapeutics Market Share by Type (2015-2020)
Table 75. India Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. India Liver Failure Therapeutics Market Share by Application (2015-2020)
Table 77. Central & South America Key Players Liver Failure Therapeutics Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players Liver Failure Therapeutics Market Share (2019-2020)
Table 79. Central & South America Liver Failure Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America Liver Failure Therapeutics Market Share by Type (2015-2020)
Table 81. Central & South America Liver Failure Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America Liver Failure Therapeutics Market Share by Application (2015-2020)
Table 83. Alfact Innovation Company Details
Table 84. Alfact Innovation Business Overview
Table 85. Alfact Innovation Product
Table 86. Alfact Innovation Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 87. Alfact Innovation Recent Development
Table 88. BioLineRx Ltd Company Details
Table 89. BioLineRx Ltd Business Overview
Table 90. BioLineRx Ltd Product
Table 91. BioLineRx Ltd Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 92. BioLineRx Ltd Recent Development
Table 93. Cell2B Advanced Therapeutics SA Company Details
Table 94. Cell2B Advanced Therapeutics SA Business Overview
Table 95. Cell2B Advanced Therapeutics SA Product
Table 96. Cell2B Advanced Therapeutics SA Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 97. Cell2B Advanced Therapeutics SA Recent Development
Table 98. Conatus Pharmaceuticals Inc Company Details
Table 99. Conatus Pharmaceuticals Inc Business Overview
Table 100. Conatus Pharmaceuticals Inc Product
Table 101. Conatus Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 102. Conatus Pharmaceuticals Inc Recent Development
Table 103. Immune Pharmaceuticals Inc Company Details
Table 104. Immune Pharmaceuticals Inc Business Overview
Table 105. Immune Pharmaceuticals Inc Product
Table 106. Immune Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 107. Immune Pharmaceuticals Inc Recent Development
Table 108. Mina Therapeutics Ltd Company Details
Table 109. Mina Therapeutics Ltd Business Overview
Table 110. Mina Therapeutics Ltd Product
Table 111. Mina Therapeutics Ltd Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 112. Mina Therapeutics Ltd Recent Development
Table 113. Mylan NV Company Details
Table 114. Mylan NV Business Overview
Table 115. Mylan NV Product
Table 116. Mylan NV Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 117. Mylan NV Recent Development
Table 118. Ocera Therapeutics Inc Business Overview
Table 119. Ocera Therapeutics Inc Product
Table 120. Ocera Therapeutics Inc Company Details
Table 121. Ocera Therapeutics Inc Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 122. Ocera Therapeutics Inc Recent Development
Table 123. PledPharma AB Company Details
Table 124. PledPharma AB Business Overview
Table 125. PledPharma AB Product
Table 126. PledPharma AB Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 127. PledPharma AB Recent Development
Table 128. Promethera Biosciences SA Company Details
Table 129. Promethera Biosciences SA Business Overview
Table 130. Promethera Biosciences SA Product
Table 131. Promethera Biosciences SA Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 132. Promethera Biosciences SA Recent Development
Table 133. Silence Therapeutics Plc Company Details
Table 134. Silence Therapeutics Plc Business Overview
Table 135. Silence Therapeutics Plc Product
Table 136. Silence Therapeutics Plc Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 137. Silence Therapeutics Plc Recent Development
Table 138. Unicyte AG Company Details
Table 139. Unicyte AG Business Overview
Table 140. Unicyte AG Product
Table 141. Unicyte AG Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 142. Unicyte AG Recent Development
Table 143. Ventria Bioscience Company Details
Table 144. Ventria Bioscience Business Overview
Table 145. Ventria Bioscience Product
Table 146. Ventria Bioscience Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 147. Ventria Bioscience Recent Development
Table 148. Vital Therapies Inc Company Details
Table 149. Vital Therapies Inc Business Overview
Table 150. Vital Therapies Inc Product
Table 151. Vital Therapies Inc Revenue in Liver Failure Therapeutics Business (2015-2020) (Million US$)
Table 152. Vital Therapies Inc Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Liver Failure Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Ornithine Phenylacetate Features
Figure 3. MTL-CEBPA Features
Figure 4. F-573 Features
Figure 5. BL-1220 Features
Figure 6. PP-100 Features
Figure 7. Others Features
Figure 8. Global Liver Failure Therapeutics Market Share by Application: 2020 VS 2026
Figure 9. Clinic Case Studies
Figure 10. Hospital Case Studies
Figure 11. Others Case Studies
Figure 12. Liver Failure Therapeutics Report Years Considered
Figure 13. Global Liver Failure Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Liver Failure Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Liver Failure Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Liver Failure Therapeutics Market Share by Players in 2019
Figure 18. Global Top Liver Failure Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Failure Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Liver Failure Therapeutics Revenue in 2019
Figure 20. North America Liver Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Liver Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Liver Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Liver Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Liver Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Liver Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Liver Failure Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Alfact Innovation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Alfact Innovation Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 29. BioLineRx Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. BioLineRx Ltd Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 31. Cell2B Advanced Therapeutics SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Cell2B Advanced Therapeutics SA Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 33. Conatus Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Conatus Pharmaceuticals Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 35. Immune Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Immune Pharmaceuticals Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 37. Mina Therapeutics Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Mina Therapeutics Ltd Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 39. Mylan NV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Mylan NV Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 41. Ocera Therapeutics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Ocera Therapeutics Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 43. PledPharma AB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. PledPharma AB Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 45. Promethera Biosciences SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Promethera Biosciences SA Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 47. Silence Therapeutics Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Silence Therapeutics Plc Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 49. Unicyte AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Unicyte AG Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 51. Ventria Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Ventria Bioscience Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 53. Vital Therapies Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Vital Therapies Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed